Baricitinib Clinical Trial Results (IMAGE)

Michigan Medicine - University of Michigan

Baricitinib Clinical Trial Results

Caption

Study results showed that diabetic kidney disease patients taking any of the three tested doses of baricitinib had lower levels of UACR in their urine than patients taking a placebo -- even after they stopped taking the drug. UACR is an indicator of kidney function.

Credit

Bariticitinib trial team

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.